Author Reply

Value Health. 2019 Aug;22(8):972-973. doi: 10.1016/j.jval.2019.03.009. Epub 2019 Jul 22.

Authors

Marita Zimmermann¹, Solomon J Lubinga², Reiner Banken³, David Rind³, Geri Cramer³, Patricia G Synnott³, Richard H Chapman³, Sonya Khan³, Josh Carlson²

Affiliations

¹ Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA. Electronic address: mm97@uw.edu.
² Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA.
³ Institute for Clinical and Economic Review, Boston, MA, USA.

PMID: 31426939
DOI: 10.1016/j.jval.2019.03.009

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Retinal Diseases*